methotrexate has been researched along with Degenerative Diseases, Central Nervous System in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Furuki, M; Hirano, K; Ito, K; Matsuda, S; Obayashi, M; Sekiguchi, N; Takaoka, K | 1 |
Amici, M; Angeletti, M; Eleuteri, AM; Pettinari, A; Pucciarelli, S; Sagratini, D | 1 |
Chemmanam, T; Krishnamoorthy, T; Kuruvilla, A; Nair, MD; Radhakrishnan, VV; Raghavendra, S | 1 |
Fujita, N; Fukuyama, T; Imashuku, S; Kobayashi, R; Koike, K; Minato, T; Morimoto, A; Nakayama, M; Okazaki, N' | 1 |
4 other study(ies) available for methotrexate and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
An Autopsy Case of Bing-Neel Syndrome: Discrepancy between the Radiological and Pathological Findings.
Topics: Autopsy; Brain Diseases; Cytarabine; Dexamethasone; Fatal Outcome; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neurodegenerative Diseases; Radiography; Waldenstrom Macroglobulinemia | 2019 |
20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders.
Topics: Animals; Cattle; Cysteine Endopeptidases; Hydrolysis; Liver; Methotrexate; Multienzyme Complexes; Neurodegenerative Diseases; Oxidation-Reduction; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Spectrometry, Fluorescence; Tetrahydrofolate Dehydrogenase | 2004 |
Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Brain Damage, Chronic; Brain Edema; Cerebral Arteries; Cognition Disorders; Dexamethasone; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Gliosis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Nerve Fibers, Myelinated; Neurodegenerative Diseases; Telencephalon; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Histiocytosis, Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Mercaptopurine; Methotrexate; Neurodegenerative Diseases; Vinblastine | 2008 |